Skip to main content
. 2016 Aug 2;8:397–406. doi: 10.2147/CEOR.S91844

Table 2.

Summary statistics of 7-month treatment costs in the study population

Treatment arms Stage IIIC ovarian cancer
Kruskal–Wallis test P-value Stage IV ovarian cancer
Kruskal–Wallis test P-value
7-month total cost of care (in 2010 US$)a
7-month total cost of care (in 2010 US$)a
n Median Mean Minimum Maximum SD n Median Mean Minimum Maximum SD
Treatment arm 0.2367 0.0299
 PDSb 2,162 59,805 68,811 14,566 583,672 41,383 1,560 63,067 71,695 8,086 740,258 41,880
 NACTb 369 62,565 67,867 4,463 252,528 31,313 427 60,442 64,813 3,237 200,885 30,898

Notes:

a

7-month total cost = Medicare payments for inpatient, outpatient, physician claims, durable medical equipment, home health, and hospice claims within 7 months after diagnosis and adjusted for inflation;

b

n=12 had missing information. Data represent all claims.

Abbreviations: NACT, neoadjuvant chemotherapy; PDS, primary debulking surgery; SD, standard deviation.